Biochemistry, Genetics and Molecular Biology
Transcription
100%
RNA Polymerase I
85%
Polymerase
66%
P53
60%
MAD1
34%
RNA Gene
29%
Nucleolus
28%
Promoter Region
28%
Mouse
26%
Transcription Factors
25%
Protein Biosynthesis
23%
Ribosome Biogenesis
23%
Cell Growth
23%
Ribosomal DNA
22%
Methylation
21%
Malignant Transformation
20%
Granulocyte Colony-Stimulating Factor
20%
Cell Proliferation
20%
DNA Damage
19%
Cancer Cell
18%
RNA
17%
RNA Sequence
17%
Cotransformation
17%
Histone Gene
17%
RNA Polymerase II
17%
Transcription Initiation
17%
Mammalian Target of Rapamycin Complex 1
17%
Fibroblast
17%
Copurification
17%
RNA Translation
17%
Myeloid
17%
DNA Methylation
17%
Liquid
17%
DNA Gyrase
17%
Cell Cycle Checkpoint
15%
Clinical Trial
15%
Gene Expression
15%
B Cell
12%
Cell Cycle Progression
11%
Phosphoinositide 3-Kinase
11%
Wild Type
9%
Myc
9%
Cell Survival
8%
Cellular Differentiation
8%
Cell Metabolism
8%
Gene Ontology
8%
Homeostasis
7%
Cooperation
7%
Signal Transduction
7%
DNA Damage Response
7%
Medicine and Dentistry
Malignant Neoplasm
53%
Ribosome
52%
RNA Polymerase I
44%
Protein P53
35%
Nucleolus
34%
Biogenesis
32%
Disease
28%
Combination Therapy
28%
Cancer Therapy
23%
Ribosome DNA
22%
Polymerase
18%
Protein Synthesis
18%
Deacetylation
17%
Mammalian Target of Rapamycin Complex 1
17%
Pancreas Adenocarcinoma
17%
Transcription Initiation
17%
RNA Translation
17%
Osteosarcoma
17%
Hematologic Malignancy
14%
Neoplasm
10%
Cell Proliferation
10%
Cell Growth
9%
DNA Damage
9%
Tumor Cell
8%
Phosphoinositide 3-Kinase
8%
Cell Cycle Checkpoint
8%
Survival Rate
8%
Clinical Trial
8%
Ataxia Telangiectasia
6%
Acute Myeloid Leukemia
6%
Everolimus
5%
Gemcitabine
5%
Chromatin Structure
5%
Genetic Transcription
5%
Prostate Cancer
5%
Fluorouracil
5%
Fibrillarin
5%
Nucleolin
5%
Programmed Cell Death
5%
Drug Delivery System
5%
Epileptic Absence
5%
RNA Gene
5%
Pharmacology, Toxicology and Pharmaceutical Science
DNA Directed RNA Polymerase
98%
Ribosome DNA
64%
Malignant Neoplasm
62%
Protein P53
46%
Acute Myeloid Leukemia
38%
Disease
23%
Leukemia
23%
Neoplasm
20%
Mouse
19%
Hematologic Malignancy
18%
Osteosarcoma
17%
Pancreas Adenocarcinoma
17%
Biotin
17%
RNA Polymerase
17%
Alkyne
17%
Azide
17%
DNA Topoisomerase (ATP Hydrolysing)
17%
Ribosome RNA
14%
Chemotherapy
10%
Combination Therapy
10%
Pharmacokinetics
8%
Antitumor Activity
8%
Survival Rate
7%
Clinical Trial
7%
Adverse Event
7%
Gemcitabine
5%
Prostate Cancer
5%
Epileptic Absence
5%
Drug Delivery System
5%
Fluorouracil
5%